2010
DOI: 10.1136/thx.2009.121640
|View full text |Cite
|
Sign up to set email alerts
|

Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 13 publications
0
7
1
Order By: Relevance
“…Studies have shown conflicting results with regard to neurologic disorders [35, 36] and asthma/COPD [36, 37]. Some have found that EPC are not decreased in COPD [38], while other investigators have shown that EPC are even influenced by whether patients are currently in a COPD exacerbation versus stable disease [39]. Thus, it is unclear at this time how these various diseases affected circulating EPC numbers in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown conflicting results with regard to neurologic disorders [35, 36] and asthma/COPD [36, 37]. Some have found that EPC are not decreased in COPD [38], while other investigators have shown that EPC are even influenced by whether patients are currently in a COPD exacerbation versus stable disease [39]. Thus, it is unclear at this time how these various diseases affected circulating EPC numbers in these patients.…”
Section: Discussionmentioning
confidence: 99%
“…This led some authors to a misclassify HPCs as EPCs in the past and resulted in conflicting interpretations regarding EPC levels and function in disease states. This is particularly true for COPD, in which levels of circulating EPCs have been reported as being either the same as controls (14) or significantly reduced (1517). A second limitation regarding studies that have measured EPCs in COPD has been the use of spirometry as the sole means of classifying subjects.…”
Section: Introductionmentioning
confidence: 94%
“…Their modulation in chronic pulmonary diseases is controversial [18]. EPC might be reduced [19,20], or not [21], in chronic obstructive pulmonary disease (COPD) as well as in hypoxemic patients with severe restrictive lung diseases [19,22]. Experimental and clinical studies have examined the potential contribution of EPC to the pathogenesis of pulmonary hypertension whether idiopathic or secondary, but again, results have been so far inconsistent [16].…”
Section: Introductionmentioning
confidence: 96%